The 10th International Bone Marrow Failure Disease Scientific Symposium will bring together physicians treating these diseases; laboratory researchers studying the genetics, genomics, and pathophysiology of bone marrow failure; and clinical investigators to discuss current areas of consensus and controversy, share recent research results, and identify the highest-priority directions for basic and clinical research to advance the field.
The past few years have seen exciting new developments in treatments for the three diseases, including new drugs and advances in bone marrow transplantation, as well as new insights into the molecular pathogenesis of the diseases. As with our previous Symposiums, this 2026 gathering of international bone marrow failure specialists will advance the knowledge of the clinical and laboratory science in these diseases and will clarify promising directions for collaborative research.
This Scientific Symposium is a unique forum that focuses on recent advances in the field and fosters robust debate both during and between the sessions. Researchers are invited to submit abstracts on innovative bone marrow failure research for the poster session on Thursday evening.
For New Investigators, the Symposium is an especially rare opportunity to interact with international bone marrow failure experts. Travel grants are available for New Investigators to attend the program.
Agenda
Note: Session times are approximate and subject to adjustment
Thursday, March 19
Time (U.S. EDT)
8:00 am – 12:15 pm Morning Session
Genetics and Genomics of Bone Marrow Failure
Session Co-Chairs: Torsten Haferlach and Christopher Reilly
Pathways of Clonal Progression Arising from Germline Predisposition
Session Co-Chairs: R. Coleman Lindsley and Marcin Wlodarski
1:00 – 7:15 pm Afternoon Session
Clonality in Acquired Bone Marrow Failure, PNH, and VEXAS
Session Co-Chairs: Emma Groarke and Yoshitaka Zaimoku
Advances in Paroxysmal Nocturnal Hemoglobinuria
Session Co-Chairs: Austin Kulasekararaj and Pedro Prata
Non-transplant Therapies for Marrow Failure
Session Co-Chairs: Carlos DeCastro and Phil Scheinberg
Transplantation for Bone Marrow Failure
Session Co-Chairs: Rick Childs and Amy DeZern
7:15 – 8:30 pm Reception and Poster Session
Note: Session times are approximate and subject to adjustment
Friday, March 20
Time (U.S. EDT)
8:00 am – 12:15 pm Morning Session
MDS and Secondary AML Pathophysiology
Session Co-Chairs: Maria (Ken) Figueroa and Jaroslaw Maciejewski
MDS Classification and Prognosis
Session Chairs: Elsa Bernard and Mateo Della Porta
1:00 – 4:00 pm Afternoon Session
Health-Related Quality of Life
Session Co-Chairs: Namrata Chandhok and Thomas LeBlanc
Treatments for MDS and Secondary AML
- Low-Risk MDS and CCUS
- Session Co-Chairs: Rena Buckstein and Valeria Santini
Treatments for MDS and Secondary AML
- High-Risk MDS and Secondary AML
- Session Co-Chairs: Hetty Carraway and Amer Zeidan
Poster Session
You are invited to participate in the Poster Session of the 2026 AAMDSIF International Bone Marrow Failure Scientific Symposium. At least one author must be registered for the Symposium to be considered for poster presentation. Encore data is eligible for submission. The deadline for submission is February 20, 2026. Abstract Submission Form
Travel Grants
The Aplastic Anemia and MDS International Foundation is pleased to offer limited travel support in the amount of $500 to New Investigators who attend the 2026 International Bone Marrow Failure Scientific Symposium. To qualify for this request, the applicant must be a post-doctoral fellow, an instructor, or an assistant professor for fewer than 5 years. New Investigator Travel Support Request Form
